---
schema_version: "secwatch.filing_event.v1"
accession: "0001641489-26-000005"
form_type: "8-K"
ticker: "VTVT"
cik: "0001641489"
company_name: "vTv Therapeutics Inc."
filed_at: "2026-02-26T23:59:59+00:00"
generated_at: "2026-05-15T23:38:53.233147+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# vTv Therapeutics posts updated investor slide presentation on February 26, 2026

## Summary
- Company posted updated investor presentation dated February 2026 on its website.
- Presentation will be used in meetings with investors, analysts, and other parties.
- Presentation attached as Exhibit 99.1 to Current Report on Form 8-K filed February 26, 2026.
- CEO Paul J. Sekhri signed the 8-K filing for vTv Therapeutics Inc. (Nasdaq: VTVT).

## SEC filing metadata
- accession: 0001641489-26-000005
- form_type: 8-K
- ticker: VTVT
- cik: 0001641489
- company_name: vTv Therapeutics Inc.
- filed_at: 2026-02-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1641489/000164148926000005/0001641489-26-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1641489/000164148926000005/vtvt-20260226.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641489-26-000005
- JSON: https://secwatch.observer/filing/0001641489-26-000005.json
- Plain text: https://secwatch.observer/filing/0001641489-26-000005.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.